Product References
The Role of Palmitic Acid in the Co-Toxicity of Bacterial Metabolites to Endothelial Cells.
Vascular health and risk management
Choroszy M,Środa-Pomianek K,Wawrzyńska M,Chmielarz M,Bożemska E,Sobieszczańska B
Published figure using VCAM-1 (CD106) recombinant monoclonal antibody (Product # MA5-31965) in Western Blot
Tue Jul 11 00:00:00 UTC 2023
Silencing of lncRNA XIST impairs angiogenesis and exacerbates cerebral vascular injury after ischemic stroke.
Molecular therapy. Nucleic acids
Wang C,Dong J,Sun J,Huang S,Wu F,Zhang X,Pang D,Fu Y,Li L
MA5-31965 was used in Western Blot to evaluate the impact of long non-coding RNA X-inactive-specific transcript in acute cerebral ischemic stroke patients, middle cerebral artery occlusion mice, and oxygen-glucose deprivation and restoration brain endothelial cells.
Fri Dec 03 00:00:00 UTC 2021
Silencing of lncRNA XIST impairs angiogenesis and exacerbates cerebral vascular injury after ischemic stroke.
Molecular therapy. Nucleic acids
Wang C,Dong J,Sun J,Huang S,Wu F,Zhang X,Pang D,Fu Y,Li L
MA5-31965 was used in Western Blot to evaluate the impact of long non-coding RNA X-inactive-specific transcript in acute cerebral ischemic stroke patients, middle cerebral artery occlusion mice, and oxygen-glucose deprivation and restoration brain endothelial cells.
Fri Dec 03 00:00:00 UTC 2021
Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice.
Frontiers in immunology
Guo Z,Chen J,Zeng Y,Wang Z,Yao M,Tomlinson S,Chen B,Yuan G,He S
MA5-31965 was used in Immunohistochemistry-frozen tissue to assess the role of complement in CLI and the therapeutic effect of the site-targeted complement inhibitor CR2-Crry in CLI.
Mon Feb 28 00:00:00 UTC 2022
Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice.
Frontiers in immunology
Guo Z,Chen J,Zeng Y,Wang Z,Yao M,Tomlinson S,Chen B,Yuan G,He S
MA5-31965 was used in Immunohistochemistry-frozen tissue to assess the role of complement in CLI and the therapeutic effect of the site-targeted complement inhibitor CR2-Crry in CLI.
Mon Feb 28 00:00:00 UTC 2022
KLF4 alleviates cerebral vascular injury by ameliorating vascular endothelial inflammation and regulating tight junction protein expression following ischemic stroke.
Journal of neuroinflammation
Zhang X,Wang L,Han Z,Dong J,Pang D,Fu Y,Li L
MA5-31965 was used in Western Blotting to examine the correlation between serum levels of CAMs/KLF4 and infarct volume in acute CIS patients.
Tue Apr 07 00:00:00 UTC 2020